AIMEDBIO
IR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Recruitment Process
Job Opportunities
Disclosure
53 posts
NO.
Title
Date
Author
53
Closure of Register of Shareholders or Designation of Record Date
2026-06-05
에임드바이오
52
Resolutions for Convocation of General Meeting of Shareholders (임시주주총회)
2026-06-05
에임드바이오
51
Material Management Information related to Judgment of Investment(Application for IND Approval)
2026-05-27
에임드바이오
50
[Corrected description]Quarterly Report (2026.03)
2026-05-15
에임드바이오
49
Quarterly Report (2026.03)
2026-05-15
에임드바이오
48
Material Management Information related to Judgment of Investment (ODS025 기술이전계약 관련 연구개발비 수령)
2026-05-06
에임드바이오
47
Report on the Grant of Stock Options
2026-03-27
에임드바이오
46
Outcomes of Annual Meeting of Shareholders
2026-03-27
에임드바이오
45
Forecast on Business Performance according to Consolidated Financial Statements(Fair Disclosure)
2026-03-26
에임드바이오
44
Annual Report (2025.12)
2026-03-19
에임드바이오
Closure of Register of Shareholders or Designation of Record Date
에임드바이오
2026-06-05
Resolutions for Convocation of General Meeting of Shareholders (임시주주총회)
에임드바이오
2026-06-05
Material Management Information related to Judgment of Investment(Application for IND Approval)
에임드바이오
2026-05-27
[Corrected description]Quarterly Report (2026.03)
에임드바이오
2026-05-15
Quarterly Report (2026.03)
에임드바이오
2026-05-15
Material Management Information related to Judgment of Investment (ODS025 기술이전계약 관련 연구개발비 수령)
에임드바이오
2026-05-06
Report on the Grant of Stock Options
에임드바이오
2026-03-27
Outcomes of Annual Meeting of Shareholders
에임드바이오
2026-03-27
Forecast on Business Performance according to Consolidated Financial Statements(Fair Disclosure)
에임드바이오
2026-03-26
Annual Report (2025.12)
에임드바이오
2026-03-19
1
2
3
4
5